Integrated clinical, genomic and functional characterization of a novel ALK variant in neuroblastoma.

Saved in:
Bibliographic Details
Title: Integrated clinical, genomic and functional characterization of a novel ALK variant in neuroblastoma.
Authors: Cañadas García A; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, CB20QQ, UK., Thombare K; Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Sweden; Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden., Jahangiri L; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, CB20QQ, UK., Burman AR; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, CB20QQ, UK., Ducray SP; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, CB20QQ, UK., Burke GAA; CRUK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Goodman A; Newcastle Genetics Laboratory, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle Upon Tyne, UK., Woodward ER; Department of Paediatric Oncology, Royal Manchester Children's Hospital, Division of Cancer Sciences, University of Manchester & Manchester Centre for Genomic Medicine, Manchester, M13 9WL, UK., Cheesman E; Department of Paediatric Oncology, Royal Manchester Children's Hospital, Division of Cancer Sciences, University of Manchester & Manchester Centre for Genomic Medicine, Manchester, M13 9WL, UK., Penn A; Department of Paediatric Oncology, Royal Manchester Children's Hospital, Division of Cancer Sciences, University of Manchester & Manchester Centre for Genomic Medicine, Manchester, M13 9WL, UK., Mondal T; Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Sweden; Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden., Turner SD; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, CB20QQ, UK; European Research Initiative for ALK Related Malignancies (ERIA), UK; Faculty of Medicine, Masaryk University, Brno, Czech Republic. Electronic address: sdt36@cam.ac.uk., Pucci P; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, CB20QQ, UK. Electronic address: pp504@cam.ac.uk.
Source: Cancer letters [Cancer Lett] 2026 Sep 28; Vol. 656, pp. 218624. Date of Electronic Publication: 2026 May 29.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1872-7980
DOI:10.1016/j.canlet.2026.218624